A pilot study of gabapentin for managing pain in children with dystonic cerebral palsy

Murdoch Childrens Research Institute0 个研究点目标入组 13 人开始时间: 2016年3月22日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•1)Confirmation of dystonia after completion of the Hypertonicity Assessment Tool (HAT). Those children who have dystonia or a mixed diagnosis (spasticity and dystonia) will be eligible.
•2)Severity of dystonia will be determined with the Barry Albright Dystonia (BAD) scale. Children with a score of 15 or higher on the BAD scale will be eligible.
•3)Pain will be quantified using the Health Utilities Index 3 (HUI 3). Those children scoring IV or V will be eligible.

•Children excluded from the study will be those who:
•1.Are younger than 6 years because they will have more difficulty with reliably self-reporting and will not be able to perform some of the quantitative measurements.
•2.Are currently on gabapentin or have been on gabapentin in the previous 3 months
•3.Have demonstrated hypersensitivity to gabapentin or the inactive ingredients in the capsules in the past
•4.Are currently taking other medications that may interact with gabapentin (i.e. antacid, cimetidine, morphine, and opioids).
•5.Pregnant female participants

发起方